Wikisage, the free encyclopedia of the second generation, is digital heritage

Diacomit

From Wikisage
Revision as of 18:59, 31 March 2016 by Penarc (talk | contribs)
Jump to navigation Jump to search

Diacomit contains 250 mg stiripentol[1]


In December 2001 the European Medicines Agency (EMA) granted stiripentol orphan drug status (designation number EU/3/01/071) for the treatment of severe myoclonic epilepsy of infancy (Dravet's syndrome). On 4 January 2007, the EMA granted the drug a marketing authorisation that is valid throughout the European Union

Dravet Syndrome does not exist data for combined therapy both valproic acid or cloabazam[2]

ATC

http://www.whocc.no/atc_ddd_index/?code=N03AX17